In This Article:
Toronto, Ontario--(Newsfile Corp. - March 22, 2022) - Leviathan Natural Products Inc. (CSE: EPIC) (OTCQB: LVCNF) (the "Company" or "Leviathan") makes the following announcements:
STOCK OPTION GRANTS
The Company announces that the board of directors on March 21, 2022, approved the granting of stock options (the "Stock Options") as compensation to Lucas Leone (the "Grantee"). The Stock Options allow the Grantee to purchase up to 2,000,000 Common Shares of the Company at an exercise price of $0.82 per share. These options vest according to the following schedule: the first 50% of the Stock Options to vest on March 21, 2023, and the remaining 50% to vest on March 21, 2024. The Stock Options expire two years from the date of vesting.
Following the grant of stock options, the Company now has a total of 8,800,000 stock options representing approximately 9.2% of the outstanding common shares of the Company.
About Leviathan Natural Products Inc.
Leviathan concentrates primarily on non-psychoactive hemp derived products for the health and wellness market. Leviathan plans on executing a series of buy and build transactions extending across all vertical markets in Canada and internationally. The Company's global capabilities position it to become a leading multi-jurisdictional cannabinoid producer - one that brings together the best cannabinoid products, brands and expertise from Canada and around the world. The Leviathan portfolio currently comprises Jekyll+Hyde Brand Builders Inc., a marketing services agency specializing in the cannabis/hemp sector; Leviathan US, Inc., which manufactures cannabidiol products from its facility in Carthage, Tennessee; LCG Holdings Inc., a planned cannabis and hemp cultivation and processing facility in Carmen de Viboral, Colombia; and Woodstock Biomed Inc., which owns a 30-acre property with greenhouse infrastructure in Pelham, Ontario. The Woodstock property operates under a lease agreement with Medical Saints Ltd., a Health Canada regulated licensed producer of industrial hemp. The agreement allows for important research and development ("R&D") in the industrial hemp sector.
For more information, please contact
Tanvi Bhandari
Chief Executive Officer
Leviathan Natural Products Inc.
Tel: 416.999.9599
tanvi@leviathan-naturals.com
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:
Certain information in this press release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or negatives of these terms and similar expressions.